Mark Hazeltine - 02 Mar 2023 Form 4 Insider Report for EXAGEN INC. (XGN)

Reporting relationship: Chief Business Officer
Issuer ticker: XGN
Reported as of: 02 Mar 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Mar 2023, 15:37:31 UTC
Prior SEC filing: 01 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Kamal Adawi, as attorney-in-fact

Key filing fact

Mark Hazeltine filed Form 4 for EXAGEN INC. (XGN) on 03 Mar 2023.

Key facts

This page summarizes Mark Hazeltine's Form 4 filing for EXAGEN INC. (XGN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Mar 2023, 15:37.

Change

Previous filing in this sequence was filed on 01 Mar 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XGN transaction

Common Stock

Sale

Transaction value: $0
Shares: -3,667
Change %: -1.9%
Price: $0.000000
Shares after: 190,205
Date: 02 Mar 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2021.